SAS: Severe Aortic Stenosis in Patients Referred for Valve Surgery

Sponsor
Oslo University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01794832
Collaborator
(none)
500
1
51.9
9.6

Study Details

Study Description

Brief Summary

Our main hypothesis on the present study is that new parameters such as risk-taking behavior, patients motivation, health related quality of life, new biomarkers and more precise echocardiography measures in addition to traditional parameters will improve pre-operative risk assessment in patients with AS and better guide patients and doctors in decision whether to operate or not.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients referred for surgery are included thorough reading referral letter. Data collected in the study wil be compared with data from Medical records and clinical examination.

    Data entered will be controlled by two investigators.

    Data wil be compared to national norms and from result of other studies.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    A Prospective Longitudinal Study of Severe Aortic Stenosis in Elderly and Outcome of Aortic Surgery.
    Study Start Date :
    Feb 1, 2010
    Anticipated Primary Completion Date :
    Apr 1, 2014
    Anticipated Study Completion Date :
    Jun 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    Elderly with severe aortic stenosis

    Patients with severe symptomatic aortic stenosis referred for consideration of surgical aortic valve replacement

    Outcome Measures

    Primary Outcome Measures

    1. Death due cardiovascular events [one year]

    Secondary Outcome Measures

    1. MACE ( Major cardiovascular events ) [30 days]

      Cerebral complications (stroke/bleeding), bleeding, renal failure, arrythmias, needs for pacemaker, prolong ICU stay, wound infections

    Other Outcome Measures

    1. Change in Health related Quality and function one year after inclusion [one year]

      Patients in the study perform Short Form-36, EuroQual-5D at inclusion and one year after. We want to compare the result of their scoring to obtain the gain in HRQoL of the intervention

    2. Hospital visit and use of Health services last years [30 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients above 18 years with symptomatic AS referred to preoperative examination.
    Exclusion Criteria:
    • Exclusion: Patients who do not want to participate. Patients not able to speak and read Norwegian.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Oslo University hospital- Rikshospitalet Oslo Norway

    Sponsors and Collaborators

    • Oslo University Hospital

    Investigators

    • Study Director: Kjell I Pettersen, MD, University of Oslo
    • Principal Investigator: Amjad I Hussain, MD, Oslo University Hosptial
    • Study Chair: Lars Gullestad, Professor, Oslo University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Amjad Iqbal Hussain, Md, Oslo University Hospital
    ClinicalTrials.gov Identifier:
    NCT01794832
    Other Study ID Numbers:
    • SAS
    First Posted:
    Feb 20, 2013
    Last Update Posted:
    Apr 3, 2014
    Last Verified:
    Apr 1, 2014
    Keywords provided by Amjad Iqbal Hussain, Md, Oslo University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 3, 2014